VHT
Vanguard Health Care ETF
Vanguard Health Care ETF seeks to track the performance of the MSCI US Investable Market Health Care Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 15.7 B
ASSETS UNDER MGMT
9 bp
EXPENSES
Fund Basics
| Inception date | Jan 26, 2004 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Delayed |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ELI LILLY & CO | 12.6 % |
| JOHNSON & JOHNSON | 8.8 % |
| ABBVIE INC | 5.9 % |
| UNITEDHEALTH GROUP INC | 5.4 % |
| MERCK & CO. INC. | 4.5 % |
| AMGEN INC | 2.9 % |
| THERMO FISHER SCIENTIFIC INC | 2.9 % |
| GILEAD SCIENCES INC | 2.7 % |
| INTUITIVE SURGICAL INC | 2.6 % |
| ABBOTT LABORATORIES | 2.5 % |
Constituent Breakdown
| Number of holdings | 412 |
| Herfindahl-Hirschman Index | 400 |
| Wgt avg mkt cap (mns) | $254,887 |
| Large cap (>$10bn) | 87.2% |
| Mid cap ($2-10bn) | 5.6% |
| Small cap (<$2bn) | 2.3% |
| Developed mkts. | 99.6% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.9 % |
 |
IRELAND | 2.3 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -5.3% | 6.5% | 3.2% | 3.5% | 2.7% | 7.9% | 8.5% | 7.9% |
| Dividend Yield | 0.4% | 1.9% | 1.7% | 1.6% | 1.5% | 1.6% | 1.7% | 1.5% |
| Total Returns | -5.0% | 8.4% | 4.8% | 5.1% | 4.2% | 9.5% | 10.2% | 9.4% | Ann. Volatility | 15.2% | 15.6% | 15.1% | 13.8% | 14.9% | 16.9% | 17.4% | 16.9% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.62 | 24% |
| MSCI EAFE | 0.61 | 32% |
| MSCI Emg Mkts | 0.32 | 15% |
Liquidity Measures
| Avg. volume (000) | 178 |
| ADV traded (mns) | $48 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.03% |
Technical Indicators
| 30d moving avg. (EMA) | $273.85 |
| Relative strength (RSI) | 45 |
| MACD/Signal | -1.67/-1.48 |
| Bollinger Bands (Upper/Lower) | $280.19/$267.03 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. VHT |
Expenses vs. VHT |
ALTAR Score™ vs. VHT |
|---|---|---|---|---|
| FHLC | Fidelity MSCI Health Care Index ETF | 91.7% | -1 bp | +0.2% |
| IYH | iShares U.S. Healthcare ETF | 87.1% | +31 bp | +0.8% |
| XLV | Health Care Select Sector SPDR | 84.7% | -1 bp | +1.6% |
| IXJ | iShares Global Healthcare ETF | 69.6% | +33 bp | +1.3% |
| HRTS | Tema Heart & Health ETF | 52.8% | +66 bp | -2.4% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 50.2% | +31 bp | +1.6% |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 44.2% | +51 bp | +1.9% |
| MEDX | Horizon Kinetics Medical ETF | 37.8% | +76 bp | -4.2% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 36.5% | +66 bp | -4.2% |
| PINK | Simplify Health Care ETF | 36.5% | +41 bp | -4.2% |
Risk and Returns: VHT vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/5/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.7%
ALTAR SCORE™
56th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,204 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. VHT's ALTAR Score™ is approximately 0.1 standard
deviations above the category average. This places VHT in the 56th percentile
among funds in the category.
Sell-Side Consensus
$338.9
PRICE TARGET
+24.9%
UPSIDE